30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

TScan Therapeutics Inc (TCRX)

Track

Stock chart
Ticker: TCRX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Lynx1 Capital Management LP
1 purchase — total 5,602 USD
Buy 23 Dec 2025
Value US$3,179,348.71 | Price 419.94 | Shares 42,657
Buy 22 Dec 2025
Value US$884,112.82 | Price 259.22 | Shares 35,424
Buy 19 Dec 2025
Value US$71,974.02 | Price 0.90 | Shares 80,069
Buy 20 May 2025
Value US$1,440,000.00 | Price 1.20 | Shares 1,200,000
Buy 19 May 2025
Value US$1,666,552.80 | Price 1.20 | Shares 1,388,794
Buy 13 Dec 2024
Value US$290,140.00 | Price 2.90 | Shares 100,000
Buy 12 Dec 2024
Value US$95,628.96 | Price 3.01 | Shares 31,800
Buy 15 Nov 2024
Value US$4,113.96 | Price 4.34 | Shares 947
Buy 23 Sep 2024
Value US$26,450.00 | Price 5.29 | Shares 5,000
Buy 26 Aug 2024
Value US$27,650.00 | Price 5.53 | Shares 5,000
Buy 23 Aug 2024
Value US$28,450.00 | Price 5.69 | Shares 5,000
Sale 23 Aug 2024
Value US$952,115.64 | Price 5.78 | Shares 164,686
Proposed sale 23 Aug 2024
Value US$905,773.00 | Price 5.50 | Shares 164,686
Buy 19 Dec 2023
Value US$1,575.01 | Price 4.97 | Shares 317
Buy 18 Dec 2023
Value US$140,880.68 | Price 4.89 | Shares 28,830
Buy 14 Dec 2023
Value US$25,400.00 | Price 5.08 | Shares 5,000
Buy 2 Jun 2023
Value US$99,563.79 | Price 2.63 | Shares 37,880
Sale 31 May 2023
Value US$1,003.00 | Price 2.51 | Shares 400
Sale 31 May 2023
Value US$37,801.50 | Price 2.52 | Shares 15,000
Sale 31 May 2023
Value US$25,148.00 | Price 2.51 | Shares 10,000
Proposed sale 15 May 2023
Value US$346,221.00 | Price 4.03 | Shares 85,911
Buy 28 Dec 2022
Value US$4,941.01 | Price 1.56 | Shares 3,158
Buy 27 Dec 2022
Value US$4,276.36 | Price 1.50 | Shares 2,842
Buy 18 May 2022
Value US$35,482.00 | Price 3.55 | Shares 10,000
Buy 18 May 2022
Value US$54,339.00 | Price 3.62 | Shares 15,000
Buy 11 May 2022
Value US$45,628.15 | Price 1.99 | Shares 22,983
Buy 11 May 2022
Value US$5,721.63 | Price 1.99 | Shares 2,882
Buy 10 May 2022
Value US$1,478,283.30 | Price 1.95 | Shares 758,094
Buy 10 May 2022
Value US$185,367.00 | Price 1.95 | Shares 95,060
Buy 10 May 2022
Value US$196,961.52 | Price 1.93 | Shares 101,831
Buy 10 May 2022
Value US$24,697.80 | Price 1.93 | Shares 12,769
Buy 10 May 2022
Value US$553,134.10 | Price 1.70 | Shares 325,373
Buy 10 May 2022
Value US$69,360.00 | Price 1.70 | Shares 40,800
Buy 24 Mar 2022
Value US$50,982.00 | Price 3.40 | Shares 15,000
Buy 23 Sep 2021
Value US$35,255.40 | Price 7.48 | Shares 4,716
Buy 9 Sep 2021
Value US$49,925.40 | Price 8.48 | Shares 5,885
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-23 2025-12-23 B Purchase
4.1
Lynx1 Capital Management LP
Large shareholder
42,657 +35.4%
419.94
US$3,179,349 		42,657 +35.4% 419.94 US$3,179,349
2025-12-23 2025-12-22 B Purchase
4.1
Lynx1 Capital Management LP
Large shareholder
35,424 -12.5%
259.22
US$884,113 		35,424 -12.5% 259.22 US$884,113
2025-12-23 2025-12-19 B Purchase
4.1
Lynx1 Capital Management LP
Large shareholder
816 -35.0%
282.57
US$4,334,147 		816 -35.0% 282.57 US$4,334,147
2025-05-21 2025-05-20 B Purchase
4.1
Lynx1 Capital Management LP
Large shareholder
1,200,000 +17.8%
1.20
US$1,440,000 		1,200,000 +17.8% 1.20 US$1,440,000
2025-05-21 2025-05-19 B Purchase
4.1
Lynx1 Capital Management LP
Large shareholder
1,388,794 +25.9%
1.20
US$1,666,553 		1,388,794 +25.9% 1.20 US$1,666,553
2024-12-16 2024-12-13 B Purchase
4.1
Lynx1 Capital Management LP
Large shareholder
100,000 +1.9%
2.90
US$290,140 		100,000 +1.9% 2.90 US$290,140
2024-12-16 2024-12-12 B Purchase
4.1
Lynx1 Capital Management LP
Large shareholder
31,800 +0.6%
3.01
US$95,629 		31,800 +0.6% 3.01 US$95,629
2024-11-19 2024-11-15 B Purchase
4.1
Lynx1 Capital Management LP
Large shareholder
947 +0.0%
4.34
US$4,114 		947 +0.0% 4.34 US$4,114
2024-09-24 2024-09-23 B Purchase
2.7
Klencke Barbara
Non-Executive Director
5,000 +12.5%
5.29
US$26,450 		5,000 +12.5% 5.29 US$26,450
2024-08-27 2024-08-26 B Purchase
2.7
Klencke Barbara
Non-Executive Director
5,000 +14.3%
5.53
US$27,650 		5,000 +14.3% 5.53 US$27,650
2024-08-27 2024-08-23 B Purchase
2.7
Klencke Barbara
Non-Executive Director
5,000 +16.7%
5.69
US$28,450 		5,000 +16.7% 5.69 US$28,450
2024-08-27 2024-08-23 S Sale
2.2
ZDRAVESKI ZORAN

See Remarks

Officer
164,686 -97.2%
5.78
US$952,116 		164,686 -97.2% 5.78 US$952,116
2024-08-23 2024-08-23 PrS Proposed sale
2.2
ZDRAVESKI ZORAN

Officer

Officer
164,686
5.50
US$905,773 		164,686 5.50 US$905,773
2023-12-21 2023-12-19 B Purchase
3.0
BARBERICH TIMOTHY J
Non-Executive Director
317 +0.5%
4.97
US$1,575 		317 +0.5% 4.97 US$1,575
2023-12-21 2023-12-18 B Purchase
3.0
BARBERICH TIMOTHY J
Non-Executive Director
28,830 +76.1%
4.89
US$140,881 		28,830 +76.1% 4.89 US$140,881
2023-12-18 2023-12-14 B Purchase
2.7
Klencke Barbara
Non-Executive Director
5,000 +20.0%
5.08
US$25,400 		5,000 +20.0% 5.08 US$25,400
2023-06-06 2023-06-02 B Purchase
3.0
BARBERICH TIMOTHY J
Non-Executive Director
37,880 +inf%
2.63
US$99,564 		37,880 +inf% 2.63 US$99,564
2023-06-02 2023-05-31 S Sale
4.1
Lynx1 Capital Management LP
Large shareholder
400 -0.0%
2.51
US$1,003 		400 -0.0% 2.51 US$1,003
2023-06-02 2023-05-31 S Sale
4.1
Lynx1 Capital Management LP
Large shareholder
15,000 -0.3%
2.52
US$37,802 		15,000 -0.3% 2.52 US$37,802
2023-06-02 2023-05-31 S Sale
4.1
Lynx1 Capital Management LP
Large shareholder
10,000 -0.2%
2.51
US$25,148 		10,000 -0.2% 2.51 US$25,148
2023-05-15 2023-05-15 PrS Proposed sale
2.9
SOUTHWELL DAVID P

Director

Non-Executive Director
85,911
4.03
US$346,221 		85,911 4.03 US$346,221
2022-12-29 2022-12-28 B Purchase
1.8
Silver Brian M.

Chief Financial Officer

Officer
3,158 +10.6%
1.56
US$4,941 		3,158 +10.6% 1.56 US$4,941
2022-12-29 2022-12-27 B Purchase
1.8
Silver Brian M.

Chief Financial Officer

Officer
2,842 +10.6%
1.50
US$4,276 		2,842 +10.6% 1.50 US$4,276
2022-05-20 2022-05-18 B Purchase
2.9
SOUTHWELL DAVID P

Chief Executive Officer

Executive Director
10,000 +6.2%
3.55
US$35,482 		10,000 +6.2% 3.55 US$35,482
2022-05-20 2022-05-18 B Purchase
2.9
SOUTHWELL DAVID P

Chief Executive Officer

Executive Director
15,000 +10.2%
3.62
US$54,339 		15,000 +10.2% 3.62 US$54,339
2022-05-12 2022-05-11 B Purchase
3.9
BAKER BROS. ADVISORS LP
Non-Executive Director Large shareholder
22,983 +0.9%
1.99
US$45,628 		22,983 +0.9% 1.99 US$45,628
2022-05-12 2022-05-11 B Purchase
3.9
BAKER BROS. ADVISORS LP
Non-Executive Director Large shareholder
2,882 +1.1%
1.99
US$5,722 		2,882 +1.1% 1.99 US$5,722
2022-05-12 2022-05-10 B Purchase
3.9
BAKER BROS. ADVISORS LP
Non-Executive Director Large shareholder
758,094 +43.4%
1.95
US$1,478,283 		758,094 +43.4% 1.95 US$1,478,283
2022-05-12 2022-05-10 B Purchase
3.9
BAKER BROS. ADVISORS LP
Non-Executive Director Large shareholder
95,060 +60.1%
1.95
US$185,367 		95,060 +60.1% 1.95 US$185,367
2022-05-12 2022-05-10 B Purchase
3.9
BAKER BROS. ADVISORS LP
Non-Executive Director Large shareholder
101,831 +6.2%
1.93
US$196,962 		101,831 +6.2% 1.93 US$196,962
2022-05-12 2022-05-10 B Purchase
3.9
BAKER BROS. ADVISORS LP
Non-Executive Director Large shareholder
12,769 +8.8%
1.93
US$24,698 		12,769 +8.8% 1.93 US$24,698
2022-05-12 2022-05-10 B Purchase
3.9
BAKER BROS. ADVISORS LP
Non-Executive Director Large shareholder
325,373 +24.6%
1.70
US$553,134 		325,373 +24.6% 1.70 US$553,134
2022-05-12 2022-05-10 B Purchase
3.9
BAKER BROS. ADVISORS LP
Non-Executive Director Large shareholder
40,800 +39.0%
1.70
US$69,360 		40,800 +39.0% 1.70 US$69,360
2022-03-28 2022-03-24 B Purchase
1.8
Silver Brian M.

Chief Financial Officer

Officer
15,000 +126.2%
3.40
US$50,982 		15,000 +126.2% 3.40 US$50,982
2021-09-27 2021-09-23 B Purchase
2.2
ZDRAVESKI ZORAN

Chief Legal Officer

Officer
4,716 +inf%
7.48
US$35,255 		4,716 +inf% 7.48 US$35,255
2021-09-13 2021-09-09 B Purchase
1.8
Silver Brian M.

Chief Financial Officer

Officer
5,885 +588.5%
8.48
US$49,925 		5,885 +588.5% 8.48 US$49,925
Explore more

More insider trading research around TScan Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America